{"@context":"https://schema.org","@type":"Corporation","name":"LINCOLN PHARMA LTD","alternateName":"LINCOLN","tickerSymbol":"LINCOLN","identifier":"LINCOLN","description":"LINCOLN PHARMA LTD (LINCOLN) financials: Market Cap ₹1,098Cr., Price ₹546, P/E 11.4, ROE 12.0%. Jun 2026: sales ₹177 Cr, net profit ₹36 Cr. Quarterly results,…","url":"https://fincrux.org/companies/LINCOLN","sameAs":["https://fincrux.org/companies/LINCOLN"],"dateModified":"2026-10-16T20:21:44.111314","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹1,098Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹546"},{"@type":"PropertyValue","name":"Stock P/E","value":"11.4"},{"@type":"PropertyValue","name":"ROE","value":"12.0%"},{"@type":"PropertyValue","name":"ROCE","value":"16.0%"},{"@type":"PropertyValue","name":"Book Value","value":"₹378"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.33%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹770/440"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/LINCOLN#webpage","name":"LINCOLN PHARMA LTD (LINCOLN) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/LINCOLN","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/LINCOLN"}}